Rep. Brian Higgins, a member of the House Cancer Caucus, has announced that Roswell Park Cancer Institute has been awarded $221,589 in grant funding from the National Cancer Institute to fund research into the disproportionate prevalence of prostate cancer in African Americans.

“I am continuously impressed by the groundbreaking research happening at Roswell Park Cancer Institute toward the goal of better understanding and ultimately finding a cure for cancer,” said Higgins, D-Buffalo. “This funding is critical to helping understand the one of the most important risk factors for prostate cancer.”

“African American men have the highest incidence rate for prostate cancer in the United States and are more than twice as likely as white men to die of the disease,” said Dr. Shahriar Koochekpour, associate professor of cancer genetics, urology and oncology at Roswell. “This grant will allow Roswell Park to research whether elevated levels of a certain amino acid, glutamate, and its receptor in African American men can predict the aggressiveness of prostate cancer and could possibly lead to better diagnostic abilities for detecting this cancer or providing novel therapeutic opportunities.”